Atopic Dermatitis
From the Journals
Inpatient cost of atopic dermatitis called ‘substantial’
Financial burden and hospitalization prevalence of atopic dermatitis is rising in the U.S.
Conference Coverage
Dupilumab improved eczema scores in children in open label trial
ORLANDO – Dupilumab is effective and well tolerated in children and adolescents with atopic dermatitis.
Conference Coverage
How will crisaborole for atopic dermatitis fit into clinical practice?
WAILEA, HAWAII – Two pediatric dermatologists involved in studies of the topical PDE-4 inhibitor provide their views on this recently approved...
Conference Coverage
Gender impacts risk of atopic diseases
ATLANTA – Obese females who live in urban settings are significantly more likely to develop atopic diseases, compared with their male counterparts...
Conference Coverage
When atopic dermatitis is really contact dermatitis
ATLANTA – What’s the best way to determine whether it’s atopic dermatitis or contact dermatitis?
Conference Coverage
Tips for taming atopic dermatitis and managing expectations
MIAMI – Even with recent FDA approval of the first new prescription agent to treat atopic dermatitis in more than 10 years, and more therapies...
Conference Coverage
VIDEO: Nonsteroidal topical expands options for pediatric AD
WAILEA, HAWAII – In a video interview, pediatric dermatologist Lawrence F. Eichenfield, MD, discusses a recently approved topical therapy for...
Conference Coverage
Topical crisaborole new option for AD
There’s a new addition to the armamentarium for atopic dermatitis: a topical phosphodiesterase 4 (PDE-4) inhibitor.
From the Journals
NIAID panel: Introduce peanut foods early to cut allergy risk
New NIAID guidelines recommend introducing peanut foods early to children at various levels of risk for peanut allergy.
News from the FDA/CDC
FDA gives nod to crisaborole for atopic dermatitis
The FDA has approved crisaborole topical ointment, 2%, to treat mild to moderate atopic dermatitis in patients 2 years of age and older.
From the Journals
Daily moisturizing to prevent AD found cost effective
Daily full-body moisturizing of babies from birth to 6 months of age was cost effective and may prove to be a simple preventive strategy to reduce...